OCCAMZRAZOR
OccamzRazor combines machine learning and first-in-class biological techniques to improve outcomes in drug discovery and development. Our analysis pipeline consists of two proprietary technologies, Panoramic AI and RazorBrain. Together, they are designed to extract data from unstructured text sources (publications, patient reported outcomes, etc.) and join them with structured data (genomics, proteomics, phenomics, etc.) to generate stronger drug discovery hypotheses and more valuable insights. Successful applications include data extraction and curation from biomedical text, novel target identification, and drug repurposing/repositioning.
OCCAMZRAZOR
Industry:
Artificial Intelligence Machine Learning Neuroscience
Founded:
2015-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.occamzrazor.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
12.35 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Domain Not Resolving Google Apps For Business Typekit
Current Advisors List
Current Employees Featured
Founder
Investors List
Lauder Partners
Lauder Partners investment in Series A - OccamzRazor
Valor Equity Partners
Valor Equity Partners investment in Series A - OccamzRazor
re.Mind Capital
re.Mind Capital investment in Series A - OccamzRazor
Jeff Dean
Jeff Dean investment in Series A - OccamzRazor
WPSS.bio
WPSS.bio investment in Convertible Note - OccamzRazor
Jeff Dean
Jeff Dean investment in Seed Round - OccamzRazor
Justin Rosenstein
Justin Rosenstein investment in Seed Round - OccamzRazor
Techammer
Techammer investment in Seed Round - OccamzRazor
Human Capital
Human Capital investment in Seed Round - OccamzRazor
Bioverge
Bioverge investment in Seed Round - OccamzRazor
Official Site Inspections
http://www.occamzrazor.com Semrush global rank: 7.27 M Semrush visits lastest month: 548
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "OccamzRazor"
Executive team - OccamzRazor
OccamzRazor is an international assembly of biomedical scientists, bioinformaticians, and AI experts. We value team spirit, humility, and constant learning. Since we come from various …See details»
OccamzRazor - Crunchbase Company Profile & Funding
OccamzRazor combines machine learning and first-in-class biological techniques to improve outcomes in drug discovery and development. Our analysis pipeline consists of two proprietary …See details»
OccamzRazor - Contacts, Employees, Board Members, Advisors
Organization. OccamzRazor . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... OccamzRazor has 2 board …See details»
OccamzRazor Company Profile 2024: Valuation, Funding
OccamzRazor was founded in 2015. Where is OccamzRazor headquartered? OccamzRazor is headquartered in New York, NY. What is the size of OccamzRazor? OccamzRazor has 12 …See details»
Disease in the digital age — OccamzRazor
OccamzRazor is a resident company of Johnson & Johnson Innovation – JLABS, a premier life science incubator program. JLABS is a global network of open innovation ecosystems, enabling and empowering innovators to create and …See details»
OccamzRazor Company Profile - Office Locations, Competitors
OccamzRazor (also known as Razor) is a digital biotech company that provides the discovery and development of modality-agnostic treatments for brain aging disease. It specializes in the …See details»
OccamzRazor - LinkedIn
OccamzRazor | 891 followers on LinkedIn. OccamzRazor pioneers novel machine learning methods to increase success in drug discovery and development. | OccamzRazor pioneers …See details»
OccamzRazor - VentureRadar
OccamzRazor is a digital biotech company that focuses on the discovery and development of modality agnostic treatments for complex diseases of brain aging. Founded by life scientists, …See details»
OccamzRazor - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Radicle Science | Katharina Sophia Volz | Forbes 30 Under 30, MIT …
Katharina is CEO and Founder of OccamzRazor, an organization using computational drug discovery to create a cure for neurodegenerative diseases. She was Stanford’s first Ph.D. in …See details»
NEXUS Impact Accelerator Fellow, Katharina Sophia Volz, Founder …
May 7, 2020 Katharina Sophia Volz is the CEO & Founder of OccamzRazor, a company that is using machine learning to fight brain-aging disorders like Parkinson’s. They recently became …See details»
OccamzRazor Closes $6.1M Financing Round - FinSMEs
Mar 8, 2022 OccamzRazor, a New York-based company creating curative treatments for complex brain-aging diseases, such as Parkinson’s disease, raised $6.1M in funding.See details»
Katharina Sophia Volz - CEO and Founder @ OccamzRazor
I’m the CEO and founder of OccamzRazor, a startup using machine learning to find treatments for brain aging diseases, starting with Parkinson’s disease. In partnership with the Stanford AI lab, …See details»
$6.1M Investment in AI Platform Targets New Treatments
Mar 10, 2022 OccamzRazor is solving this problem,” the company states on its website. Using machine learning — a form of AI — OccamzRazor can analyze large biomedical datasets, and …See details»
Manifesto — OccamzRazor
OccamzRazor is a digital biotech company that focuses on the discovery and development of modality agnostic treatments for complex diseases of brain aging. Founded by life scientists, …See details»
OccamzRazor announces closing of $6.1M financing round to …
Mar 8, 2022 OccamzRazor was founded to help patients with brain-aging disorders where there is a lack of treatment options that halt or reverse the disease. Drug development in brain-aging …See details»
"Labeled training data is the new oil" — OccamzRazor
Our digital scientist technology combines knowledge extraction and graph learning “Labeled training data is the new new oil.” Christopher Ré, Stanford. Together, with world leading …See details»
OccamzRazor announces closing of $6.1M financing round to …
Mar 29, 2022 OccamzRazor is on a mission to create the first curative treatments for complex brain-aging diseases, such as Parkinson's disease. The company recently received …See details»
News & Updates — OccamzRazor
Oct 27, 2022 OccamzRazor has received $6.1 million in investments to support its artificial intelligence (AI)- based platform aimed at accelerating the identification of new therapeutic …See details»